Artivion (AORT) Net Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Artivion | 1.02 Bn | 961.00 Mn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 563.00 |
| Dec 31, 2025 | 718.00 |
| Sep 30, 2025 | 1,014.00 |
| Jun 30, 2025 | 805.00 |
| Mar 31, 2025 | 952.00 |
| Dec 31, 2024 | -360.00 |
| Sep 30, 2024 | -219.00 |
| Jun 30, 2024 | -614.00 |
| Mar 31, 2024 | 817.00 |
| Dec 31, 2023 | 363.00 |
| Sep 30, 2023 | -1,358.00 |
| Jun 30, 2023 | -412.00 |
| Mar 31, 2023 | -1,004.00 |
| Dec 31, 2022 | 2,039.00 |
| Sep 30, 2022 | -2,086.00 |
| Jun 30, 2022 | -1,192.00 |
| Mar 31, 2022 | -932.00 |
| Dec 31, 2021 | -3,776.00 |
| Sep 30, 2021 | 804.00 |
| Jun 30, 2021 | -785.00 |
| Mar 31, 2021 | -1,032.00 |
| Dec 31, 2020 | 260.00 |
| Sep 30, 2020 | -1,025.00 |
| Jun 30, 2020 | -545.00 |
| Mar 31, 2020 | -922.00 |
| Dec 31, 2019 | -1,812.00 |
| Sep 30, 2019 | -647.00 |
| Jun 30, 2019 | -225.00 |
| Mar 31, 2019 | -340.00 |
| Dec 31, 2018 | -3,424.00 |
| Sep 30, 2018 | -632.00 |
| Jun 30, 2018 | -500.00 |
| Mar 31, 2018 | -1,239.00 |
| Dec 31, 2017 | 1,162.00 |
| Sep 30, 2017 | -159.00 |
| Jun 30, 2017 | -320.00 |
| Mar 31, 2017 | 187.00 |
| Dec 31, 2016 | 631.00 |
| Sep 30, 2016 | -19.00 |
| Jun 30, 2016 | -107.00 |
| Mar 31, 2016 | 39.00 |
| Dec 31, 2015 | -903.00 |
| Sep 30, 2015 | 1,650.00 |
| Jun 30, 2015 | -1,141.00 |